Abstract
A Fullerene based system is modified in order to increase its solubility and enhance its ability to carry a protein-like structure. The modified structure, which is proposed to act as HIV-1 protease inhibitor, is [C60–C2H4N–(2,4- XCOCH2OH)C6H4], where the X atom is either O, S or Se. The geometry optimization, vibrational spectra and thermodynamics were performed using semiempirical quantum mechanical PM3 method in order to study the proposed compounds. Furthermore, the quantitative structure activity relationship (QSAR) properties of the compounds are calculated at the same level of theory. Results indicate a possible use of the investigated structures as HIV-1 protease inhibitors. The compounds containing oxygen is more stable as compared to the other two compounds.
Keywords: Fulleropyrrolidine, HIV-1 Protease, Hydroxymethylcarbonyl group (HMC), Molecular modeling, QSAR, hydrophilic, chalcogen atoms, polarizability, hydroxyl groups, agrochemicals, mono-functionalization, ring-junction
Mini-Reviews in Medicinal Chemistry
Title:Fullerene Derivative as Anti-HIV Protease Inhibitor: Molecular Modeling and QSAR Approaches
Volume: 12 Issue: 6
Author(s): M. Ibrahim, N. A. Saleh, W. M. Elshemey and A. A. Elsayed
Affiliation:
Keywords: Fulleropyrrolidine, HIV-1 Protease, Hydroxymethylcarbonyl group (HMC), Molecular modeling, QSAR, hydrophilic, chalcogen atoms, polarizability, hydroxyl groups, agrochemicals, mono-functionalization, ring-junction
Abstract: A Fullerene based system is modified in order to increase its solubility and enhance its ability to carry a protein-like structure. The modified structure, which is proposed to act as HIV-1 protease inhibitor, is [C60–C2H4N–(2,4- XCOCH2OH)C6H4], where the X atom is either O, S or Se. The geometry optimization, vibrational spectra and thermodynamics were performed using semiempirical quantum mechanical PM3 method in order to study the proposed compounds. Furthermore, the quantitative structure activity relationship (QSAR) properties of the compounds are calculated at the same level of theory. Results indicate a possible use of the investigated structures as HIV-1 protease inhibitors. The compounds containing oxygen is more stable as compared to the other two compounds.
Export Options
About this article
Cite this article as:
Ibrahim M., A. Saleh N., M. Elshemey W. and A. Elsayed A., Fullerene Derivative as Anti-HIV Protease Inhibitor: Molecular Modeling and QSAR Approaches, Mini-Reviews in Medicinal Chemistry 2012; 12 (6) . https://dx.doi.org/10.2174/138955712800493762
DOI https://dx.doi.org/10.2174/138955712800493762 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Strategic Leukofiltration in Cardiac Surgery
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Chelating Agents for Metal Intoxication
Current Medicinal Chemistry CD95 Signaling in Cancer Treatment
Current Pharmaceutical Design Non-Hormonal Replacement Therapy Regimens: Do they have an Effect on Cardiovascular Risk?
Current Vascular Pharmacology Is the Therapeutic Potential of Stem Cells for Myocardial Regeneration Limited by Proarrhythmic Effects?
Current Cardiology Reviews The JPJDF has Synergistic Effect with Fluoropyrimidine in the Maintenance Therapy for Metastatic Colorectal Cancer
Recent Patents on Anti-Cancer Drug Discovery Fiber-Optic Technologies in Laser-Based Therapeutics: Threads for a Cure
Current Pharmaceutical Biotechnology Recent Patents on Non-Contact Electrodes for Measuring EEG and EKG
Recent Patents on Electrical & Electronic Engineering Human Carbonyl Reductases
Current Drug Metabolism Impact of Cardiovascular Factors on Pulse Wave Velocity and Total Vascular Resistance in Different Age Group Patients with Cardiovascular Disorders
Current Aging Science A Review of Nanocarrier-Based CNS Delivery Systems
Current Drug Delivery Pulmonary Hypertension in Idiopathic Pulmonary Fibrosis
Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued) A Review on the Risk of Myocardial Infarction Associated with the NSAID Diclofenac
Cardiovascular & Hematological Disorders-Drug Targets Anticancer Drugs in Liposomal Nanodevices: A Target Delivery for a Targeted Therapy
Current Topics in Medicinal Chemistry Targeting Antioxidants to Mitochondria: A Potential New Therapeutic Strategy for Cardiovascular Diseases
Current Pharmaceutical Design Adverse Bioeffects of Ultrasound Contrast Agents Used in Echocardiography: True Safety Issue or “Much Ado About Nothing”?
Current Vascular Pharmacology TRAIL Gene Therapy: From Preclinical Development to Clinical Application
Current Gene Therapy Mechanisms in the Development of Multiple Sclerosis Lesions: Reconciling Autoimmune and Neurodegenerative Factors
CNS & Neurological Disorders - Drug Targets Insights Into the Molecular Aspects of Neuroprotective Bacoside A and Bacopaside I
Current Neuropharmacology Different Patterns of Statin Use in Patients with Acute Myocardial Infarction
Current Vascular Pharmacology